healthcare reform
Smaller labs, hospital outreach labs, and labs servicing high numbers of elderly are thought to face the highest risks.
2010 in Review: Genomic Medicine Experiences Growing Pains of Regulation, Economics, and Litigation
Premium
The amount of activity last year on the regulatory, reimbursement, legislative, educational, and intellectual property fronts is a sign that the wheels are slowly shifting toward creating a framework that will someday support and deliver genomically guided medicine, even though plenty of barriers and challenges need to be overcome on the path to that goal.
The healthcare reform bill includes a section on comparative effectiveness research that creates the Patient-Centered Outcomes Research Institute. Seen as a victory for personalized medicine, the institute will study the utility of medical products in "various subpopulations," including groups differentiated by genetic and molecular subtypes.
Personalized Medicine Looks to Take Step Forward with US Healthcare Reform Plan
The healthcare reform bill, expected to be signed into law by President Obama on March 23, includes a section on comparative effectiveness research that creates the Patient-Centered Outcomes Research Institute.
Sebelius Cites Support for Genomics in HHS Confirmation Hearing
In a hearing overshadowed by a looming healthcare debate, the secretary-designate cited genomics research first in her list of important HHS duties.